24,996 Shares in Centene Corporation $CNC Acquired by Fieldview Capital Management LLC

Fieldview Capital Management LLC bought a new position in Centene Corporation (NYSE:CNC) during the 4th quarter, Holdings Channel reports. The institutional investor bought 24,996 shares of the company’s stock, valued at approximately $1,029,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in Centene by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 56,978,753 shares of the company’s stock worth $2,344,676,000 after purchasing an additional 190,334 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Centene by 76.6% in the third quarter. AQR Capital Management LLC now owns 14,654,834 shares of the company’s stock worth $522,885,000 after purchasing an additional 6,356,152 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Centene by 5.5% in the fourth quarter. Geode Capital Management LLC now owns 13,271,492 shares of the company’s stock worth $554,338,000 after purchasing an additional 697,277 shares during the last quarter. Deerfield Management Company L.P. boosted its holdings in Centene by 184.0% in the third quarter. Deerfield Management Company L.P. now owns 9,046,000 shares of the company’s stock worth $322,761,000 after purchasing an additional 5,860,630 shares during the last quarter. Finally, Morgan Stanley boosted its holdings in Centene by 7.2% in the fourth quarter. Morgan Stanley now owns 9,002,570 shares of the company’s stock worth $370,456,000 after purchasing an additional 603,585 shares during the last quarter. Hedge funds and other institutional investors own 93.63% of the company’s stock.

Centene Stock Down 0.0%

Shares of CNC stock opened at $65.18 on Monday. The stock has a market cap of $32.18 billion, a P/E ratio of -4.96, a PEG ratio of 0.51 and a beta of 1.09. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $66.55. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.76. The company’s fifty day simple moving average is $51.43 and its two-hundred day simple moving average is $44.36.

Centene (NYSE:CNC) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, topping the consensus estimate of $2.23 by $1.14. The business had revenue of $49.94 billion for the quarter, compared to analysts’ expectations of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $2.90 EPS. Analysts predict that Centene Corporation will post 3.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on CNC shares. Robert W. Baird lifted their price target on shares of Centene from $36.00 to $37.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 15th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Centene in a research note on Thursday. Oppenheimer lifted their price target on shares of Centene from $58.00 to $67.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. Zacks Research upgraded shares of Centene from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, May 6th. Finally, Bank of America lifted their price target on shares of Centene from $72.00 to $74.00 and gave the stock a “buy” rating in a research note on Thursday, June 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Centene presently has a consensus rating of “Hold” and an average target price of $60.24.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.